IMM 1.45% 34.0¢ immutep limited

experimental ovarian cancer vaccine offers h.., page-2

  1. 375 Posts.

    they do seem to have referred to this trial as a phase II trial. It's not, it's obviously the phase III trial - phase II is fully recruited. So it looks like recruitment is now starting for phase III which makes sense. That's a great milestone.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.